120 related articles for article (PubMed ID: 38073379)
21. TROP-2 and 5hmC expression in follicular-patterned thyroid neoplasm emphasizing tiny well-formed papillae.
Seok JY; Fan X
Ann Diagn Pathol; 2022 Apr; 57():151903. PubMed ID: 35121239
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and pathological differences between papillary thyroid carcinoma with Graves' disease and papillary thyroid carcinoma with Hashimoto's thyroiditis].
Xu DD; Lun Y; Liu X; Jiang H; Song JB; Duan ZQ; Xin SJ; Zhang J
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2491-2495. PubMed ID: 28835054
[No Abstract] [Full Text] [Related]
23. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic utility of CK19 and galectin-3 in differentiating papillary thyroid carcinoma from nonneoplastic lesions of thyroid.
Prasad PA; Raju K
J Cancer Res Ther; 2022; 18(3):644-649. PubMed ID: 35900535
[TBL] [Abstract][Full Text] [Related]
25. Hashimoto's thyroiditis, nodular goiter or follicular adenoma combined with papillary thyroid carcinoma play protective role in patients.
Ma H; Li L; Li K; Wang T; Zhang Y; Zhang C; Xu Y; Wu X; Yu J; Wang H; Xiang B; Zhang R; Wang W
Neoplasma; 2018 Mar; 65(3):436-440. PubMed ID: 29788738
[TBL] [Abstract][Full Text] [Related]
26. The absence of CD56 expression can differentiate papillary thyroid carcinoma from other thyroid lesions.
Golu I; Vlad MM; Dema A; Moleriu LC; Tudor A; Iacob M; Popa O; Cornianu M
Indian J Pathol Microbiol; 2017; 60(2):161-166. PubMed ID: 28631628
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.
El Demellawy D; Nasr AL; Babay S; Alowami S
Pathol Res Pract; 2009; 205(5):303-9. PubMed ID: 19153015
[TBL] [Abstract][Full Text] [Related]
28. Stomatin-like protein 2 is associated with the clinicopathological features of human papillary thyroid cancer and is regulated by TGF-β in thyroid cancer cells.
Liu Z; Yang Y; Zhang Y; Ye X; Wang L; Xu G
Oncol Rep; 2014 Jan; 31(1):153-60. PubMed ID: 24190591
[TBL] [Abstract][Full Text] [Related]
29. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological profile of papillary carcinoma of thyroid: A 10-year experience in a tertiary care institute in North Karnataka, India.
Rao R; Giriyan SS; Rangappa PK
Indian J Cancer; 2017; 54(3):514-518. PubMed ID: 29798949
[TBL] [Abstract][Full Text] [Related]
31. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
Jiang XL; Zhang H; Chen YL; Peng L
Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
[No Abstract] [Full Text] [Related]
32. Higher incidence of tall cell variant of papillary thyroid carcinoma in Graves' Disease.
Boutzios G; Vasileiadis I; Zapanti E; Charitoudis G; Karakostas E; Ieromonachou P; Karatzas T
Thyroid; 2014 Feb; 24(2):347-54. PubMed ID: 23786233
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of the Follicular Variant of Papillary Thyroid Carcinoma From Classic Papillary Thyroid Carcinoma: An Ultrasound Analysis and Complement to Fine-Needle Aspiration Cytology.
Ng SC; Kuo SF; Hua CC; Huang BY; Chiang KC; Chu YY; Hsueh C; Lin JD
J Ultrasound Med; 2018 Mar; 37(3):667-674. PubMed ID: 28880405
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
Abouhashem NS; Talaat SM
Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
[TBL] [Abstract][Full Text] [Related]
35. The Potential Diagnostic Utility of TROP-2 in Thyroid Neoplasms.
Liu H; Shi J; Lin F
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):525-533. PubMed ID: 26862947
[TBL] [Abstract][Full Text] [Related]
36. Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid.
El Demellawy D; Nasr A; Alowami S
Diagn Pathol; 2008 Feb; 3():5. PubMed ID: 18254952
[TBL] [Abstract][Full Text] [Related]
37. The clinical usefulness of chemokine C-X-C Motif Ligand 12 as a diagnostic marker for Papillary Thyroid Carcinoma.
Lee SA; Choi JH; Cho SJ; Chang JW; Maeng YH
Indian J Pathol Microbiol; 2020; 63(4):544-550. PubMed ID: 33154303
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Value of TROP2 Expression in Papillary Thyroid Carcinoma.
Saffar H; Jahanbin B; Ameli F; Farhang F; Tavangar SM; Saffar H
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):218-222. PubMed ID: 33264108
[TBL] [Abstract][Full Text] [Related]
39. [The expression and significance of trefoil factor 3 and SDF-1/CXCR4 biological axis in papillary thyroid carcinoma].
Xue G; Huang J; Zhang H; Zhang W; Wu J; Shang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jan; 28(2):108-12. PubMed ID: 24738314
[TBL] [Abstract][Full Text] [Related]
40. A comparative study of nuclear 8-hydroxyguanosine expression in Autoimmune Thyroid Diseases and Papillary Thyroid Carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins.
Mseddi M; Ben Mansour R; Gouiia N; Mnif F; Bousselaa R; Abid M; Boudaouara T; Attia H; Lassoued S
Adv Med Sci; 2017 Mar; 62(1):45-51. PubMed ID: 28187375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
